Medications that mimic GLP-1 are designed to enhance these functions, making them effective tools for managing type 2 diabetes and, more recently, promoting weight loss
Ultimately, for future clinical applications, such as evaluating the metabolic resilience of engineered CAR-T cells, relying on a single optical modality is insufficient
Hes not only eating healthier and exercising more, but also using Zepbound, one of the new GLP-1 drugs, to control his appetite
Tirzepatide works by targeting GLP-1 AND GIP receptors which stimulates the release of insulin and reduces the time for the stomach to empty its contents
Access this article Similar content being viewed by others References GBD 2021 Diabetes Collaborators
doi: 10.2215/CJN.05240515 226